Literature DB >> 31103248

Corrigendum to "ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway" [Cancer Lett. 454 (2019) 179-190].

Yan Li1, Lei Tao1, Zeping Zuo1, Yang Zhou2, Xinying Qian1, Yiyun Lin1, Hui Jie1, Chunqi Liu1, Zhuoling Li1, Huaqin Zhang1, Hu Zhang3, Xiaobo Cen4, Shengyong Yang5, Yinglan Zhao6.   

Abstract

Entities:  

Year:  2019        PMID： 31103248     DOI： 10.1016/j.canlet.2019.05.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


× No keyword cloud information.
  1 in total

1.  Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models.

Authors:  Alessia Romussi; Anna Cappa; Paola Vianello; Silvia Brambillasca; Maria Rosaria Cera; Roberto Dal Zuffo; Giovanni Fagà; Raimondo Fattori; Loris Moretti; Paolo Trifirò; Manuela Villa; Stefania Vultaggio; Valentina Cecatiello; Sebastiano Pasqualato; Giulio Dondio; Chi Wai Eric So; Saverio Minucci; Luca Sartori; Mario Varasi; Ciro Mercurio
Journal:  ACS Med Chem Lett       Date:  2020-02-13       Impact factor: 4.345
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.